Hippocratic AI valued at $1.64 billion after series B round

Hippocratic AI raised $141 million in a series B funding round, led by Kleiner Perkins, investors include A16z, NVIDIA, and General Catalyst. The company, cofounded by healthcare experts, focuses on AI in healthcare.

iStock
Hippocratic AI notched a valuation of $1.64 billion after its latest fund raise led by Kleiner Perkins, the VC firm that backed Google, Amazon, and Genentech as AI funding thrives.

The company said on Thursday it had raised $141 million in a series B funding round, which brings its total raise to $278 million in funding.

Kleiner was joined by existing investors A16z, General Catalyst, Premji, NVIDIA, SV Angel, Universal Health Services , and WellSpan Health.


Technology-focused startups have been able to secure a chunk of investments following a boom in artificial intelligence after the launch of Open AI's ChatGPT in 2022.

Hippocratic AI was cofounded by CEO Munjal Shah alongside a group of physicians, hospital administrators, healthcare professionals, and artificial intelligence researchers from El Camino Health, Johns Hopkins, Stanford, Microsoft, Google, and NVIDIA.
Download
The Economic Times Business News App
for the Latest News in Business, Sensex, Stock Market Updates & More.
Download
The Economic Times News App
for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
READ MORE
ADVERTISEMENT

READ MORE:

LOGIN & CLAIM

50 TIMESPOINTS

More from our Partners

Loading next story
Business News › Tech › Funding › Hippocratic AI valued at $1.64 billion after series B round
Text Size:AAA
Success
This article has been saved

*

+